Litcius/Paper detail

3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity

Jangho Lee, Ji‐Hye Song, Min‐Yu Chung, Jin-Hyuk Lee, Tae‐gyu Nam, Jae Ho Park, Jin‐Taek Hwang, Hyo‐Kyoung Choi

2020Acta Pharmacologica Sinica26 citationsDOIOpen Access PDF

Topics & Concepts

MetaboliteRutinNonalcoholic fatty liver diseaseAcetylationHistoneHistone acetyltransferasePharmacologyFatty liverBiochemistryArylamine N-acetyltransferaseChemistryMedicineDiseaseInternal medicineGeneAntioxidantLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseCholesterol and Lipid Metabolism
3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity | Litcius